Search

Author/Creator Twomey, Patrick

2. Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study. Issue 6 (June 2022)

Authors:
Cho, Byoung Chul; Abreu, Delvys Rodriguez; Hussein, Maen; Cobo, Manuel; Patel, Anjan J; Secen, Nevena; Lee, Ki Hyeong; Massuti, Bartomeu; Hiret, Sandrine; Yang, James Chih Hsin; Barlesi, Fabrice; Lee, Dae Ho; Ares, Luis Paz; Hsieh, Robert W; Patil, Namrata S; Twomey, Patrick; Yang, Xiaoying; Meng...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 6(2022)
Page Start:
781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacokinetics of Ipatasertib in Subjects With Hepatic Impairment Using 2 Methods of Classification of Hepatic Function. (23rd December 2021)

Authors:
Sane, Rucha; Malhi, Vikram; Sutaria, Dhruvitkumar S; Cho, Eunpi; Twomey, Patrick; Craggs, Christopher; Wang, Jianshuang; Harris, Adam; Musib, Luna
Journal:
Journal of clinical pharmacology
Issue:
Volume 62:Number 2(2022)
Page Start:
171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗